The calcium-cancer signalling nexus.
Identifieur interne : 000228 ( Main/Merge ); précédent : 000227; suivant : 000229The calcium-cancer signalling nexus.
Auteurs : Gregory R. Monteith [Australie] ; Natalia Prevarskaya [France] ; Sarah J. Roberts-Thomson [Australie]Source :
- Nature reviews. Cancer [ 1474-1768 ] ; 2017.
Descripteurs français
- KwdFr :
- MESH :
- anatomopathologie : Tumeurs.
- physiologie : Signalisation du calcium.
- étiologie : Tumeurs.
- Humains, Tumeurs.
English descriptors
- KwdEn :
- MESH :
- etiology : Neoplasms.
- pathology : Neoplasms.
- physiology : Calcium Signaling.
- therapy : Neoplasms.
- Humans.
Abstract
The calcium signal is a powerful and multifaceted tool by which cells can achieve specific outcomes. Cellular machinery important in tumour progression is often driven or influenced by changes in calcium ions; in some cases this regulation occurs within spatially defined regions. Over the past decade there has been a deeper understanding of how calcium signalling is remodelled in some cancers and the consequences of calcium signalling on key events such as proliferation, invasion and sensitivity to cell death. Specific calcium signalling pathways have also now been identified as playing important roles in the establishment and maintenance of multidrug resistance and the tumour microenvironment.
DOI: 10.1038/nrc.2017.18
PubMed: 28386091
Links toward previous steps (curation, corpus...)
- to stream PubMed, to step Corpus: 000B45
- to stream PubMed, to step Curation: 000B42
- to stream PubMed, to step Checkpoint: 000B42
- to stream Ncbi, to step Merge: 004599
- to stream Ncbi, to step Curation: 004599
- to stream Ncbi, to step Checkpoint: 004599
Links to Exploration step
pubmed:28386091Le document en format XML
<record><TEI><teiHeader><fileDesc><titleStmt><title xml:lang="en">The calcium-cancer signalling nexus.</title>
<author><name sortKey="Monteith, Gregory R" sort="Monteith, Gregory R" uniqKey="Monteith G" first="Gregory R" last="Monteith">Gregory R. Monteith</name>
<affiliation wicri:level="1"><nlm:affiliation>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102</wicri:regionArea>
<wicri:noRegion>Queensland 4102</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Prevarskaya, Natalia" sort="Prevarskaya, Natalia" uniqKey="Prevarskaya N" first="Natalia" last="Prevarskaya">Natalia Prevarskaya</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut National de la Santé et de la Recherche Médicale U1003, Laboratoire de Physiologie Cellulaire, Equipe labellisée par la Ligue contre le cancer, and Universite de Lille 1, Villeneuve d'Ascq, F-59650, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U1003, Laboratoire de Physiologie Cellulaire, Equipe labellisée par la Ligue contre le cancer, and Universite de Lille 1, Villeneuve d'Ascq, F-59650</wicri:regionArea>
<wicri:noRegion>59650</wicri:noRegion>
<wicri:noRegion>59650</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Roberts Thomson, Sarah J" sort="Roberts Thomson, Sarah J" uniqKey="Roberts Thomson S" first="Sarah J" last="Roberts-Thomson">Sarah J. Roberts-Thomson</name>
<affiliation wicri:level="1"><nlm:affiliation>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102</wicri:regionArea>
<wicri:noRegion>Queensland 4102</wicri:noRegion>
</affiliation>
</author>
</titleStmt>
<publicationStmt><idno type="wicri:source">PubMed</idno>
<date when="2017">2017</date>
<idno type="RBID">pubmed:28386091</idno>
<idno type="pmid">28386091</idno>
<idno type="doi">10.1038/nrc.2017.18</idno>
<idno type="wicri:Area/PubMed/Corpus">000B45</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Corpus" wicri:corpus="PubMed">000B45</idno>
<idno type="wicri:Area/PubMed/Curation">000B42</idno>
<idno type="wicri:explorRef" wicri:stream="PubMed" wicri:step="Curation">000B42</idno>
<idno type="wicri:Area/PubMed/Checkpoint">000B42</idno>
<idno type="wicri:explorRef" wicri:stream="Checkpoint" wicri:step="PubMed">000B42</idno>
<idno type="wicri:Area/Ncbi/Merge">004599</idno>
<idno type="wicri:Area/Ncbi/Curation">004599</idno>
<idno type="wicri:Area/Ncbi/Checkpoint">004599</idno>
<idno type="wicri:Area/Main/Merge">000228</idno>
</publicationStmt>
<sourceDesc><biblStruct><analytic><title xml:lang="en">The calcium-cancer signalling nexus.</title>
<author><name sortKey="Monteith, Gregory R" sort="Monteith, Gregory R" uniqKey="Monteith G" first="Gregory R" last="Monteith">Gregory R. Monteith</name>
<affiliation wicri:level="1"><nlm:affiliation>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102</wicri:regionArea>
<wicri:noRegion>Queensland 4102</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Prevarskaya, Natalia" sort="Prevarskaya, Natalia" uniqKey="Prevarskaya N" first="Natalia" last="Prevarskaya">Natalia Prevarskaya</name>
<affiliation wicri:level="1"><nlm:affiliation>Institut National de la Santé et de la Recherche Médicale U1003, Laboratoire de Physiologie Cellulaire, Equipe labellisée par la Ligue contre le cancer, and Universite de Lille 1, Villeneuve d'Ascq, F-59650, France.</nlm:affiliation>
<country xml:lang="fr">France</country>
<wicri:regionArea>Institut National de la Santé et de la Recherche Médicale U1003, Laboratoire de Physiologie Cellulaire, Equipe labellisée par la Ligue contre le cancer, and Universite de Lille 1, Villeneuve d'Ascq, F-59650</wicri:regionArea>
<wicri:noRegion>59650</wicri:noRegion>
<wicri:noRegion>59650</wicri:noRegion>
</affiliation>
</author>
<author><name sortKey="Roberts Thomson, Sarah J" sort="Roberts Thomson, Sarah J" uniqKey="Roberts Thomson S" first="Sarah J" last="Roberts-Thomson">Sarah J. Roberts-Thomson</name>
<affiliation wicri:level="1"><nlm:affiliation>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102, Australia.</nlm:affiliation>
<country xml:lang="fr">Australie</country>
<wicri:regionArea>The School of Pharmacy, Pharmacy Australia Centre of Excellence, The University of Queensland, Brisbane, Queensland 4102</wicri:regionArea>
<wicri:noRegion>Queensland 4102</wicri:noRegion>
</affiliation>
</author>
</analytic>
<series><title level="j">Nature reviews. Cancer</title>
<idno type="eISSN">1474-1768</idno>
<imprint><date when="2017" type="published">2017</date>
</imprint>
</series>
</biblStruct>
</sourceDesc>
</fileDesc>
<profileDesc><textClass><keywords scheme="KwdEn" xml:lang="en"><term>Calcium Signaling (physiology)</term>
<term>Humans</term>
<term>Neoplasms (etiology)</term>
<term>Neoplasms (pathology)</term>
<term>Neoplasms (therapy)</term>
</keywords>
<keywords scheme="KwdFr" xml:lang="fr"><term>Humains</term>
<term>Signalisation du calcium (physiologie)</term>
<term>Tumeurs ()</term>
<term>Tumeurs (anatomopathologie)</term>
<term>Tumeurs (étiologie)</term>
</keywords>
<keywords scheme="MESH" qualifier="anatomopathologie" xml:lang="fr"><term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" qualifier="etiology" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="pathology" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="physiologie" xml:lang="fr"><term>Signalisation du calcium</term>
</keywords>
<keywords scheme="MESH" qualifier="physiology" xml:lang="en"><term>Calcium Signaling</term>
</keywords>
<keywords scheme="MESH" qualifier="therapy" xml:lang="en"><term>Neoplasms</term>
</keywords>
<keywords scheme="MESH" qualifier="étiologie" xml:lang="fr"><term>Tumeurs</term>
</keywords>
<keywords scheme="MESH" xml:lang="en"><term>Humans</term>
</keywords>
<keywords scheme="MESH" xml:lang="fr"><term>Humains</term>
<term>Tumeurs</term>
</keywords>
</textClass>
</profileDesc>
</teiHeader>
<front><div type="abstract" xml:lang="en">The calcium signal is a powerful and multifaceted tool by which cells can achieve specific outcomes. Cellular machinery important in tumour progression is often driven or influenced by changes in calcium ions; in some cases this regulation occurs within spatially defined regions. Over the past decade there has been a deeper understanding of how calcium signalling is remodelled in some cancers and the consequences of calcium signalling on key events such as proliferation, invasion and sensitivity to cell death. Specific calcium signalling pathways have also now been identified as playing important roles in the establishment and maintenance of multidrug resistance and the tumour microenvironment.</div>
</front>
</TEI>
</record>
Pour manipuler ce document sous Unix (Dilib)
EXPLOR_STEP=$WICRI_ROOT/Wicri/Asie/explor/AustralieFrV1/Data/Main/Merge
HfdSelect -h $EXPLOR_STEP/biblio.hfd -nk 000228 | SxmlIndent | more
Ou
HfdSelect -h $EXPLOR_AREA/Data/Main/Merge/biblio.hfd -nk 000228 | SxmlIndent | more
Pour mettre un lien sur cette page dans le réseau Wicri
{{Explor lien |wiki= Wicri/Asie |area= AustralieFrV1 |flux= Main |étape= Merge |type= RBID |clé= pubmed:28386091 |texte= The calcium-cancer signalling nexus. }}
Pour générer des pages wiki
HfdIndexSelect -h $EXPLOR_AREA/Data/Main/Merge/RBID.i -Sk "pubmed:28386091" \ | HfdSelect -Kh $EXPLOR_AREA/Data/Main/Merge/biblio.hfd \ | NlmPubMed2Wicri -a AustralieFrV1
This area was generated with Dilib version V0.6.33. |